CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 study evaluating adjunctive aripiprazole added to antidepressant therapy for major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED